Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients

Preoperative Evaluation of Endometrial Cancer

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02560571

Enrollment

200

Registered

2015-09-25

Start date

2015-10-31

Completion date

Unknown

Last updated

2016-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Cancer

Brief summary

The study evaluates pre-operative prediction of the risk for lymph nodes involvement in endometrial cancer patients. Patients will undergo ultrasound exam (bi and three dimensional) and biomarker test - Ca 125, in addition to routine physical and laboratory exams, before surgery. The sonographic evaluation will include endometrial characteristics and myometrial invasion, pelvic findings and enlarged lymph nodes.

Interventions

DEVICEultrasound

OTHERblood test

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Endometrial cancer patients * Surgical candidates

Exclusion criteria

* Fertility preservation therapy * Contraindication for surgery * Stage 2 and higher

Design outcomes

Primary

Measure	Time frame
number of participants with positive nodes	4 weeks after surgery (4-6 weeks from enrollment)

Countries

Israel

Contacts

Primary Contactyfat kadan, md

yfat_ka@clalit.org.il972-9-7471575

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026